HealthPartners Medical Policy Updates – October 2018

Click here to view the HealthPartners Medical Policy Updates »

October 2018 HealthPartners Medical Policy Updates:

• Atypical antipsychotic injections (Abilify Maintena™, Aristada™, and Zyprexa® Relprevv™) – Minnesota Health Care Programs
• Avelumab (Bavencio®) – Minnesota Health Care Programs
• Belatacept (Nulojix®) – Minnesota Health Care Programs
• Benralizumab (Fasenra™) – Minnesota Health Care Programs
• Bezlotoxumab (Zinplava™) – Minnesota Health Care Programs
• Bone stimulator, electronic and ultrasonic
• Bone stimulators, electronic and ultrasonic -Minnesota Health Care Programs
• Botulinum toxins: abobotulinumtoxinA (Dysport®), incobotulinumtoxinA (Xeomin®), onabotulinumtoxinA (Botox®), & rimabotulinumtoxinB (Myobloc®) – Effective 1/1/2018
• Cerliponase alfa (Brineura™) – Minnesota Health Care Programs
• Chorionic gonadotropin (Novarel® and Synarel®) – Minnesota Health Care Programs
• Compression support garments
• Compression support garments – Minnesota Health Care Programs
• DME Benefits Grid
• Edaravone (Radicava®) – Minnesota Health Care Programs
• Etelcalcetide (Parsabiv™) – Minnesota Health Care Programs
• Exondys 51™ – Minnesota Health Care Programs
• Eyewear – Minnesota Health Care Programs
• Hearing Aids
• Hearing Aids – Minnesota Health Care Programs
• Heart failure pressure sensor, implantable (i.e., CardioMEMS HF System)
• Hereditary angioedema (HAE) drug therapy – Minnesota Health Care Programs
• Hydroxyprogesterone caproate (Makena®) – Minnesota Health Care Programs
• Inotuzumab ozogamicin (Besponsa™) – Minnesota Health Care Programs
• Investigational services – list of non-covered services
• Ipilimumab (Yervoy®) – Minnesota Health Care Programs
• Mepolizumab (Nucala®) – Minnesota Health Care Programs
• Non-surgical treatment for gender dysphoria
• Oncology drug coverage – Effective 1/1/2018
• Sacral nerve stimulation for fecal incontinence
• Stereotactic radiosurgery and stereotactic body radiation therapy
• Synagis (palivizumab) injections for respiratory syncytial virus (RSV) prophylaxis
• Synagis (palivizumab) injections for respiratory syncytial virus (RSV) prophylaxis – Minnesota Health Care Programs
• Vagus Nerve Stimulation (VNS)
• Weight Loss Management

Click here to view the HealthPartners Medical Policy Updates »

Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.

Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!

Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.

Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.